Swiss National Bank’s Cymabay Therapeutics CBAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-155,400
Closed -$3.67M 2542
2023
Q4
$3.67M Sell
155,400
-26,100
-14% -$465K ﹤0.01% 1477
2023
Q3
$2.71M Buy
181,500
+22,600
+14% +$300K ﹤0.01% 1654
2023
Q2
$1.74M Sell
158,900
-23,800
-13% -$222K ﹤0.01% 1980
2023
Q1
$1.59M Buy
+182,700
New +$1.46M ﹤0.01% 1979
2021
Q2
Sell
-109,000
Closed -$495K 2655
2021
Q1
$495K Hold
109,000
﹤0.01% 2457
2020
Q4
$626K Buy
+109,000
New +$825K ﹤0.01% 2430
2020
Q2
Sell
-118,400
Closed -$175K 2528
2020
Q1
$175K Hold
118,400
﹤0.01% 2424
2019
Q4
$232K Buy
118,400
+2,500
+2% +$9.39K ﹤0.01% 2501
2019
Q3
$593K Buy
115,900
+3,000
+3% +$18.2K ﹤0.01% 2296
2019
Q2
$808K Buy
112,900
+2,300
+2% +$26K ﹤0.01% 2231
2019
Q1
$1.47M Buy
110,600
+11,400
+11% +$121K ﹤0.01% 1856
2018
Q4
$781K Buy
99,200
+2,500
+3% +$23.8K ﹤0.01% 2137
2018
Q3
$1.07M Hold
96,700
﹤0.01% 2112
2018
Q2
$1.3M Buy
+96,700
New +$1.21M ﹤0.01% 2002

Other funds holding CBAY